FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2106453040> ?p ?o ?g. }

• W2106453040 endingPage "818" @default.
• W2106453040 startingPage "811" @default.
• W2106453040 abstract "Abstract Objective —To determine toxic effects of streptozocin given in combination with a diuresis protocol in dogs and establish whether streptozocin is efficacious in treatment of pancreatic islet cell tumors in dogs. Design —Retrospective study. Animals —17 dogs. Procedure —Medical records were reviewed to obtain information regarding signalment, tumor stage and staging tests performed, number of streptozocin treatments, adverse effects, results of biochemical and hematologic monitoring during streptozocin treatment, tumor dimensions, duration of normoglycemia, and date of death, when applicable. Dogs were compared with a historical control group of 15 dogs treated surgically and medically. Results —58 treatments were administered to the 17 dogs. Only 1 dog developed azotemia. Serum alanine aminotransferase activity increased in some dogs but decreased when treatment was discontinued. Hematologic toxicoses were rare. Vomiting during administration was uncommon but occasionally severe. Two dogs developed diabetes mellitus after receiving 5 doses. Median duration of normoglycemia for 14 dogs with stage-II or -III insulinoma treated with streptozocin was 163 days (95% confidence interval, 16 to 309 days), which was not significantly different from that for the control dogs (90 days; 95% confidence interval, 0 to 426 days). Two dogs had rapid resolution of paraneoplastic peripheral neuropathy, and 2 others had measurable reductions in tumor size. Conclusions and Clinical Relevance —Results suggest that streptozocin can be administered safely to dogs at a dosage of 500 mg/m 2 , IV, every 3 weeks when combined with a protocol for induction of diuresis and may be efficacious in the treatment of dogs with metastatic pancreatic islet cell tumors. ( J Am Vet Med Assoc 2002;221:811–818)" @default.
• W2106453040 created "2016-06-24" @default.
• W2106453040 creator A5009353441 @default.
• W2106453040 creator A5011685200 @default.
• W2106453040 creator A5032716520 @default.
• W2106453040 creator A5041720417 @default.
• W2106453040 creator A5052479441 @default.
• W2106453040 creator A5072042052 @default.
• W2106453040 creator A5075749316 @default.
• W2106453040 date "2002-09-15" @default.
• W2106453040 modified "2023-10-10" @default.
• W2106453040 title "Streptozocin for treatment of pancreatic islet cell tumors in dogs: 17 cases (1989–1999)" @default.
• W2106453040 cites W1967612457 @default.
• W2106453040 cites W1976419899 @default.
• W2106453040 cites W2004333510 @default.
• W2106453040 cites W2021752936 @default.
• W2106453040 cites W2027163803 @default.
• W2106453040 cites W2032551896 @default.
• W2106453040 cites W2046520858 @default.
• W2106453040 cites W2051922232 @default.
• W2106453040 cites W2071418215 @default.
• W2106453040 cites W2085753486 @default.
• W2106453040 cites W2091260221 @default.
• W2106453040 cites W2092292588 @default.
• W2106453040 cites W2326849431 @default.
• W2106453040 cites W38682668 @default.
• W2106453040 doi "https://doi.org/10.2460/javma.2002.221.811" @default.
• W2106453040 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12322919" @default.
• W2106453040 hasPublicationYear "2002" @default.
• W2106453040 type Work @default.
• W2106453040 sameAs 2106453040 @default.
• W2106453040 citedByCount "54" @default.
• W2106453040 countsByYear W21064530402012 @default.
• W2106453040 countsByYear W21064530402013 @default.
• W2106453040 countsByYear W21064530402014 @default.
• W2106453040 countsByYear W21064530402015 @default.
• W2106453040 countsByYear W21064530402016 @default.
• W2106453040 countsByYear W21064530402017 @default.
• W2106453040 countsByYear W21064530402018 @default.
• W2106453040 countsByYear W21064530402019 @default.
• W2106453040 countsByYear W21064530402020 @default.
• W2106453040 countsByYear W21064530402021 @default.
• W2106453040 countsByYear W21064530402022 @default.
• W2106453040 countsByYear W21064530402023 @default.
• W2106453040 crossrefType "journal-article" @default.
• W2106453040 hasAuthorship W2106453040A5009353441 @default.
• W2106453040 hasAuthorship W2106453040A5011685200 @default.
• W2106453040 hasAuthorship W2106453040A5032716520 @default.
• W2106453040 hasAuthorship W2106453040A5041720417 @default.
• W2106453040 hasAuthorship W2106453040A5052479441 @default.
• W2106453040 hasAuthorship W2106453040A5072042052 @default.
• W2106453040 hasAuthorship W2106453040A5075749316 @default.
• W2106453040 hasConcept C126322002 @default.
• W2106453040 hasConcept C134018914 @default.
• W2106453040 hasConcept C141071460 @default.
• W2106453040 hasConcept C159641895 @default.
• W2106453040 hasConcept C165220095 @default.
• W2106453040 hasConcept C197934379 @default.
• W2106453040 hasConcept C2775919214 @default.
• W2106453040 hasConcept C2776297358 @default.
• W2106453040 hasConcept C2778242168 @default.
• W2106453040 hasConcept C2779280383 @default.
• W2106453040 hasConcept C2779547328 @default.
• W2106453040 hasConcept C2780091579 @default.
• W2106453040 hasConcept C2780852908 @default.
• W2106453040 hasConcept C2781025020 @default.
• W2106453040 hasConcept C2911120302 @default.
• W2106453040 hasConcept C555293320 @default.
• W2106453040 hasConcept C71924100 @default.
• W2106453040 hasConcept C90924648 @default.
• W2106453040 hasConceptScore W2106453040C126322002 @default.
• W2106453040 hasConceptScore W2106453040C134018914 @default.
• W2106453040 hasConceptScore W2106453040C141071460 @default.
• W2106453040 hasConceptScore W2106453040C159641895 @default.
• W2106453040 hasConceptScore W2106453040C165220095 @default.
• W2106453040 hasConceptScore W2106453040C197934379 @default.
• W2106453040 hasConceptScore W2106453040C2775919214 @default.
• W2106453040 hasConceptScore W2106453040C2776297358 @default.
• W2106453040 hasConceptScore W2106453040C2778242168 @default.
• W2106453040 hasConceptScore W2106453040C2779280383 @default.
• W2106453040 hasConceptScore W2106453040C2779547328 @default.
• W2106453040 hasConceptScore W2106453040C2780091579 @default.
• W2106453040 hasConceptScore W2106453040C2780852908 @default.
• W2106453040 hasConceptScore W2106453040C2781025020 @default.
• W2106453040 hasConceptScore W2106453040C2911120302 @default.
• W2106453040 hasConceptScore W2106453040C555293320 @default.
• W2106453040 hasConceptScore W2106453040C71924100 @default.
• W2106453040 hasConceptScore W2106453040C90924648 @default.
• W2106453040 hasIssue "6" @default.
• W2106453040 hasLocation W21064530401 @default.
• W2106453040 hasLocation W21064530402 @default.
• W2106453040 hasOpenAccess W2106453040 @default.
• W2106453040 hasPrimaryLocation W21064530401 @default.
• W2106453040 hasRelatedWork W1963751275 @default.
• W2106453040 hasRelatedWork W2082326400 @default.
• W2106453040 hasRelatedWork W2375975265 @default.
• W2106453040 hasRelatedWork W2391997785 @default.
• W2106453040 hasRelatedWork W2394762135 @default.

• next